These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 19723320)

  • 1. Cost-effectiveness of fibronectin testing in a triage in women with threatened preterm labor: alleviation of pregnancy outcome by suspending tocolysis in early labor (APOSTEL-I trial).
    Vis JY; Wilms FF; Oudijk MA; Porath MM; Scheepers HC; Bloemenkamp KW; Bolte AC; Cornette J; Derks JB; Duvekot JJ; van Eyck J; Kwee A; Opmeer BC; van Pampus MG; Lotgering FK; Scherjon SA; Sollie KM; Spaanderman ME; Willekes C; van der Post JA; Mol BW
    BMC Pregnancy Childbirth; 2009 Sep; 9():38. PubMed ID: 19723320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of perinatal outcome after sustained tocolysis in early labour (APOSTEL-II trial).
    Roos C; Scheepers LH; Bloemenkamp KW; Bolte A; Cornette J; Derks JB; Duvekot HJ; van Eyck J; Kok JH; Kwee A; Merién A; Opmeer BC; van Pampus MG; Papatsonis DN; Porath MM; van der Post JA; Scherjon SA; Sollie K; Spaanderman ME; Vijgen SM; Willekes C; Mol BW; Lotgering FK
    BMC Pregnancy Childbirth; 2009 Sep; 9():42. PubMed ID: 19737426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of a cervical pessary for women who did not deliver 48 h after threatened preterm labor (Assessment of perinatal outcome after specific treatment in early labor: Apostel VI trial).
    Hermans FJ; Schuit E; Opmeer BC; Oudijk MA; Bekker M; Woiski M; Bax CJ; Sueters M; Scheepers HC; Franssen MT; Pajkrt E; Mol BW; Kok M
    BMC Pregnancy Childbirth; 2016 Jul; 16(1):154. PubMed ID: 27405353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nifedipine versus atosiban in the treatment of threatened preterm labour (Assessment of Perinatal Outcome after Specific Tocolysis in Early Labour: APOSTEL III-Trial).
    van Vliet EO; Schuit E; Heida KY; Opmeer BC; Kok M; Gyselaers W; Porath MM; Woiski M; Bax CJ; Bloemenkamp KW; Scheepers HC; Jaquemyn Y; van Beek E; Duvekot HJ; Franssen MT; Bijvank BN; Kok JH; Franx A; Mol BW; Oudijk MA
    BMC Pregnancy Childbirth; 2014 Mar; 14():93. PubMed ID: 24589124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study protocol for a randomised trial for atosiban versus placebo in threatened preterm birth: the APOSTEL 8 study.
    Klumper J; Breebaart W; Roos C; Naaktgeboren CA; van der Post J; Bosmans J; van Kaam A; Schuit E; Mol BW; Baalman J; McAuliffe F; Thornton J; Kok M; Oudijk MA
    BMJ Open; 2019 Nov; 9(11):e029101. PubMed ID: 31772083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nifedipine versus placebo in the treatment of preterm prelabor rupture of membranes: a randomized controlled trial: Assessment of perinatal outcome by use of tocolysis in early labor-APOSTEL IV trial.
    Nijman TA; van Vliet EO; Naaktgeboren CA; Oude Rengerink K; de Lange TS; Bax CJ; Bloemenkamp KW; van Eyck J; Kok M; Scheepers HC; Woiski M; Franx A; Mol BW; Oudijk MA
    Eur J Obstet Gynecol Reprod Biol; 2016 Oct; 205():79-84. PubMed ID: 27567363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fetal fibronectin testing for prevention of preterm birth in singleton pregnancies with threatened preterm labor: a systematic review and metaanalysis of randomized controlled trials.
    Berghella V; Saccone G
    Am J Obstet Gynecol; 2016 Oct; 215(4):431-8. PubMed ID: 27133012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The NIFTY study: a multicentre randomised double-blind placebo-controlled trial of nifedipine maintenance tocolysis in fetal fibronectin-positive women in threatened preterm labour.
    Parry E; Roos C; Stone P; Hayward L; Mol BW; McCowan L
    Aust N Z J Obstet Gynaecol; 2014 Jun; 54(3):231-6. PubMed ID: 24506318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized comparison of nifedipine and placebo in fibronectin-negative women with symptoms of preterm labor and a short cervix (APOSTEL-I Trial).
    Vis JY; van Baaren GJ; Wilms FF; Oudijk MA; Kwee A; Porath MM; Scheepers HC; Spaanderman ME; Bloemenkamp KW; van Lith JM; Bolte AC; Bax CJ; Cornette J; Duvekot JJ; Nij Bijvank SW; van Eyck J; Franssen MT; Sollie KM; Woiski M; Vandenbussche FP; van der Post JA; Bossuyt PM; Opmeer BC; Mol BW
    Am J Perinatol; 2015 Apr; 32(5):451-60. PubMed ID: 25486290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The predictive value of quantitative fibronectin testing in combination with cervical length measurement in symptomatic women.
    Bruijn MM; Kamphuis EI; Hoesli IM; Martinez de Tejada B; Loccufier AR; Kühnert M; Helmer H; Franz M; Porath MM; Oudijk MA; Jacquemyn Y; Schulzke SM; Vetter G; Hoste G; Vis JY; Kok M; Mol BW; van Baaren GJ
    Am J Obstet Gynecol; 2016 Dec; 215(6):793.e1-793.e8. PubMed ID: 27542720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of maintenance tocolysis with nifedipine in threatened preterm labor on perinatal outcomes: a randomized controlled trial.
    Roos C; Spaanderman ME; Schuit E; Bloemenkamp KW; Bolte AC; Cornette J; Duvekot JJ; van Eyck J; Franssen MT; de Groot CJ; Kok JH; Kwee A; Merién A; Nij Bijvank B; Opmeer BC; Oudijk MA; van Pampus MG; Papatsonis DN; Porath MM; Scheepers HC; Scherjon SA; Sollie KM; Vijgen SM; Willekes C; Mol BW; van der Post JA; Lotgering FK;
    JAMA; 2013 Jan; 309(1):41-7. PubMed ID: 23280223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tocolysis in the management of preterm prelabor rupture of membranes at 22-33 weeks of gestation: study protocol for a multicenter, double-blind, randomized controlled trial comparing nifedipine with placebo (TOCOPROM).
    Lorthe E; Kayem G;
    BMC Pregnancy Childbirth; 2021 Sep; 21(1):614. PubMed ID: 34496799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effectiveness of nifedipine/indomethacin combination therapy and nifedipine monotherapy for postponing preterm birth (25-34 weeks of gestation) in Sudanese women: a randomized clinical trial study protocol.
    Ibrahim MH; Elfaki T; Elhassan EM; Abdelrahiem SK; Adam I
    BMC Pregnancy Childbirth; 2021 Jun; 21(1):457. PubMed ID: 34187394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting preterm birth: a cost-effectiveness analysis.
    Mozurkewich EL; Naglie G; Krahn MD; Hayashi RH
    Am J Obstet Gynecol; 2000 Jun; 182(6):1589-98. PubMed ID: 10871482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prognostic model, including quantitative fetal fibronectin, to predict preterm labour: the QUIDS meta-analysis and prospective cohort study.
    Stock SJ; Horne M; Bruijn M; White H; Heggie R; Wotherspoon L; Boyd K; Aucott L; Morris RK; Dorling J; Jackson L; Chandiramani M; David A; Khalil A; Shennan A; Baaren GV; Hodgetts-Morton V; Lavender T; Schuit E; Harper-Clarke S; Mol B; Riley RD; Norman J; Norrie J
    Health Technol Assess; 2021 Sep; 25(52):1-168. PubMed ID: 34498576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fetal fibronectin status and cervical length in women with threatened preterm labor and the effectiveness of maintenance tocolysis.
    Roos C; Vis JY; Scheepers HC; Bloemenkamp KW; Duvekot HJ; van Eyck J; de Groot C; Kok JH; Opmeer BC; Oudijk MA; Papatsonis DN; Porath MM; Sollie K; Spaanderman ME; Lotgering FK; van der Post JA; Mol BW
    J Matern Fetal Neonatal Med; 2016; 29(10):1556-61. PubMed ID: 26103778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of a randomized trial on maintenance tocolysis on length of hospital admission of women with threatened preterm labor in The Netherlands.
    Lange TS; Roos C; Bloemenkamp KW; Bolte AC; Duvekot JJ; Franssen MT; Kok M; Oudijk MA; Porath MM; van der Post JA; Mol BW
    Eur J Obstet Gynecol Reprod Biol; 2015 Mar; 186():8-11. PubMed ID: 25596476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maintenance tocolysis with nifedipine in threatened preterm labour: 2-year follow up of the offspring in the APOSTEL II trial.
    van Vliet E; Seinen L; Roos C; Schuit E; Scheepers H; Bloemenkamp K; Duvekot JJ; van Eyck J; Kok JH; Lotgering FK; van Baar A; van Wassenaer-Leemhuis AG; Franssen MT; Porath MM; van der Post J; Franx A; Mol B; Oudijk MA
    BJOG; 2016 Jun; 123(7):1107-14. PubMed ID: 26330379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening to prevent spontaneous preterm birth: systematic reviews of accuracy and effectiveness literature with economic modelling.
    Honest H; Forbes CA; Durée KH; Norman G; Duffy SB; Tsourapas A; Roberts TE; Barton PM; Jowett SM; Hyde CJ; Khan KS
    Health Technol Assess; 2009 Sep; 13(43):1-627. PubMed ID: 19796569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cervical pessary for preventing preterm birth in twin pregnancies with maternal short cervix after an episode of threatened preterm labor: randomised controlled trial.
    Merced C; Goya M; Pratcorona L; Rodó C; Llurba E; Higueras T; Cabero L; Carreras E;
    Am J Obstet Gynecol; 2019 Jul; 221(1):55.e1-55.e14. PubMed ID: 30826339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.